Cleared Traditional

K992397 - ACCUNATE-ONE STEP

K992397 is the FDA 510(k) clearance for ACCUNATE-ONE STEP by Cenogenics Corp.. It is a Class 2 Chemistry device (product code JHI) cleared through the Traditional 510(k) pathway after a 38-day FDA review.

K992397 · Cenogenics Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1999
Decision
38d
Days
Class 2
Risk

K992397 is an FDA 510(k) clearance for the ACCUNATE-ONE STEP, ACCUNATE-ONE STEP CASSETTE. Classified as Visual, Pregnancy Hcg, Prescription Use (product code JHI), Class II - Special Controls.

Submitted by Cenogenics Corp. (Morganville, US). The FDA issued a Cleared decision on August 26, 1999 after a review of 38 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1155 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Cenogenics Corp. devices

Submission Details

510(k) Number K992397 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 19, 1999
Decision Date August 26, 1999
Days to Decision 38 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
50d faster than avg
Panel avg: 88d · This submission: 38d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JHI Visual, Pregnancy Hcg, Prescription Use
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1155
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JHI Visual, Pregnancy Hcg, Prescription Use

All 189
Devices cleared under the same product code (JHI) and FDA review panel - the closest regulatory comparables to K992397.
ACON ONE STEP PREGNANCY TEST STRIP (URINE)
K993203 · ACON Laboratories, Inc. · Dec 1999
ACON HCG ONE STEP PREGNANCY TEST DEVICE (URINE)
K993317 · ACON Laboratories, Inc. · Dec 1999
ACON COMBO PREGNANCY
K993065 · ACON Laboratories, Inc. · Oct 1999
MODIFICATION OF SAS SERUM/URINE HCG
K990684 · Sa Scientific, Inc. · May 1999
SAS ONE-STEP PREGNANCY
K990741 · Sa Scientific, Inc. · May 1999
QUICKCARD HCG COMBO TEST, MODEL #9014
K991095 · Phamatech · Apr 1999